Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids.


Journal

STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501

Informations de publication

Date de publication:
19 03 2021
Historique:
entrez: 31 3 2021
pubmed: 1 4 2021
medline: 1 4 2021
Statut: epublish

Résumé

We developed a modified protocol, based on differential ultracentrifugation (dUC), to isolate extracellular vesicles and particles (specifically exomeres) (EVPs) from various human and murine sources, including cell lines, surgically resected tumors and adjacent tissues, and bodily fluids, such as blood, lymphatic fluid, and bile. The diversity of these samples requires robust and highly reproducible protocols and refined isolation technology, such as asymmetric-flow field-flow fractionation (AF4). Our isolation protocol allows for preparation of EVPs for various downstream applications, including proteomic profiling. For complete details on the use and execution of this protocol, please refer to Hoshino et al. (2020).

Identifiants

pubmed: 33786456
doi: 10.1016/j.xpro.2020.100225
pii: S2666-1667(20)30212-4
pmc: PMC7988237
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

100225

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218513
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002384
Pays : United States

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

D.L., A.H., H.S.K., and L.B. have filed a US patent application related to this work.

Références

Nature. 2005 Jul 28;436(7050):518-24
pubmed: 16049480
Cancer Res. 2018 Jul 1;78(13):3688-3697
pubmed: 29735554
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
J Immunol Methods. 2002 Dec 15;270(2):211-26
pubmed: 12379326
Nat Commun. 2018 Jan 12;9(1):175
pubmed: 29330365
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Lab Chip. 2010 Feb 21;10(4):505-11
pubmed: 20126692
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
J Extracell Vesicles. 2013 Jun 18;2:
pubmed: 24009888
Proteomics Clin Appl. 2010 Jan;4(1):84-96
pubmed: 21137018
Sci Rep. 2016 Sep 23;6:33935
pubmed: 27659060
Methods. 2012 Feb;56(2):293-304
pubmed: 22285593
J Vis Exp. 2012 Jan 09;(59):e3037
pubmed: 22257828
Nat Protoc. 2019 Apr;14(4):1027-1053
pubmed: 30833697
Nat Cell Biol. 2018 Mar;20(3):332-343
pubmed: 29459780
Sci Rep. 2020 Jan 23;10(1):1039
pubmed: 31974468
Nat Protoc. 2020 Jan;15(1):40-67
pubmed: 31776460

Auteurs

Linda Bojmar (L)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58183, Sweden.

Han Sang Kim (HS)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Gabriel C Tobias (GC)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil.

Fanny A Pelissier Vatter (FA)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.

Serena Lucotti (S)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.

Kofi Ennu Gyan (KE)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
Tri-Institutional PhD Program in Computational Biology and Medicine, New York, NY, USA.

Candia M Kenific (CM)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.

Zurong Wan (Z)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.

Kyung-A Kim (KA)

Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

DooA Kim (D)

Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

Jonathan Hernandez (J)

Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Virginia Pascual (V)

Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
Drukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.

Todd E Heaton (TE)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Michael P La Quaglia (MP)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David Kelsen (D)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Tanya M Trippett (TM)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David R Jones (DR)

Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

William R Jarnagin (WR)

Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Irina R Matei (IR)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.

Haiying Zhang (H)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.

Ayuko Hoshino (A)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.

David Lyden (D)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH